11 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 56.3% per year over the past 5 years.
Operating margin has expanded, at -50.2% in the latest year.
Financial health
Operating income covered interest expense -44.0× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 4.3 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$457M
-$176M
58.3%
-50.2%
-$159M
—
$680M
2024
$398M
-$257M
63.0%
-71.0%
-$221M
—
$450M
2023
$267M
-$335M
64.1%
-137.4%
-$205M
—
$790M
2022
$213M
-$443M
65.2%
-190.1%
-$392M
—
$1.0B
2021
$144M
-$705M
0.0%
-485.8%
-$568M
—
$964M
2020
$49M
-$269M
0.0%
-616.4%
-$226M
—
$442M
2019
$13M
-$195M
0.0%
-1564.9%
-$197M
—
$76M
2018
$129000
-$139M
66.6%
-109897.7%
-$108M
—
$63M
2017
—
-$50M
—
—
-$41M
—
$230M
2016
—
-$38M
—
—
-$34M
—
$84M
2015
—
-$18M
—
—
—
—
$13M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$96M
-$51M
59.9%
-72.6%
-$13M
—
$651M
Dec '25
$127M
-$50M
51.0%
-54.6%
-$27M
—
$680M
Sep '25
$115M
-$36M
59.5%
-42.3%
-$35M
—
$717M
Jun '25
$109M
-$41M
60.6%
-50.3%
-$34M
—
$732M
Mar '25
$106M
-$48M
63.6%
-53.3%
-$63M
—
$757M
Dec '24
$109M
-$82M
61.5%
-62.6%
-$58M
—
$450M
Sep '24
$102M
-$42M
64.1%
-66.6%
-$28M
—
$616M
Jun '24
$100M
-$80M
64.9%
-76.0%
-$43M
—
$630M
Mar '24
$87M
-$53M
61.4%
-80.7%
-$91M
—
$651M
Dec '23
$66M
-$95M
61.7%
-188.3%
-$15M
—
$790M
Sep '23
$69M
-$69M
63.2%
-120.7%
-$57M
—
$789M
Jun '23
$69M
-$121M
65.5%
-130.0%
-$60M
—
$859M
Mar '23
$63M
-$49M
0.0%
-110.7%
-$73M
—
$880M
Dec '22
$62M
-$62M
0.0%
-156.8%
-$114M
—
$1.0B
Sep '22
$57M
-$161M
0.0%
-225.7%
-$133M
—
$1.1B
Jun '22
$48M
-$138M
0.0%
-207.5%
-$49M
—
$681M
Mar '22
$46M
-$82M
0.0%
-173.0%
-$97M
—
$847M
Dec '21
$44M
-$212M
0.0%
-498.6%
-$159M
—
$964M
Sep '21
$43M
-$96M
0.0%
-193.0%
-$167M
—
$1.4B
Jun '21
$37M
-$163M
0.0%
-461.8%
-$70M
—
$1.8B
Valuation over time
How the market has priced ZLAB against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 171.5× (Mar '23) to 44.4× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is ZLAB growing its revenue and profit?
Over the past 5 years, Zai Lab Ltd's revenue has grown 56.3% per year. These are computed facts, not advice.
How much debt does ZLAB have?
As of FY2025, Zai Lab Ltd reported — of total debt against $680M of cash; operating income covered interest expense -44.0×.
What is ZLAB's profit margin?
In FY2025, gross margin was 58.3%, operating margin -50.2%, and net margin -38.4%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.